Clinical Trials Directory

Trials / Completed

CompletedNCT00108589

S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
US Department of Veterans Affairs · Federal
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A placebo controlled trial will then examine the effect of S-adenosylmethionine over time on clinical outcome in these patients. It is expected that this agent will slow or halt the progression of this disease.

Conditions

Interventions

TypeNameDescription
DRUGS-adenosylmethionine

Timeline

Start date
2004-01-01
Completion
2006-12-01
First posted
2005-04-18
Last updated
2009-01-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00108589. Inclusion in this directory is not an endorsement.